308 related articles for article (PubMed ID: 25639278)
1. Ten-day triple therapy versus sequential therapy versus concomitant therapy as first-line treatment for Helicobacter pylori infection.
Ang TL; Fock KM; Song M; Ang D; Kwek AB; Ong J; Tan J; Teo EK; Dhamodaran S
J Gastroenterol Hepatol; 2015 Jul; 30(7):1134-9. PubMed ID: 25639278
[TBL] [Abstract][Full Text] [Related]
2. Ten-day high-dose proton pump inhibitor triple therapy versus sequential therapy for Helicobacter pylori eradication.
Auesomwang C; Maneerattanaporn M; Chey WD; Kiratisin P; Leelakusolwong S; Tanwandee T
J Gastroenterol Hepatol; 2018 Nov; 33(11):1822-1828. PubMed ID: 29804294
[TBL] [Abstract][Full Text] [Related]
3. Concomitant versus sequential therapy for the treatment of Helicobacter pylori infection: a Greek randomized prospective study.
Apostolopoulos P; Koumoutsos I; Ekmektzoglou K; Dogantzis P; Vlachou E; Kalantzis C; Tsibouris P; Alexandrakis G
Scand J Gastroenterol; 2016; 51(2):145-51. PubMed ID: 26435055
[TBL] [Abstract][Full Text] [Related]
4. Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for
Kim BJ; Lee H; Lee YC; Jeon SW; Kim GH; Kim HS; Sung JK; Lee DH; Kim HU; Park MI; Choi IJ; Yoon SM; Kim SW; Baik GH; Lee JY; Kim JI; Kim SG; Kim J; Lee J; Kim JG; Kim JJ;
Gut Liver; 2019 Sep; 13(5):531-540. PubMed ID: 31505907
[TBL] [Abstract][Full Text] [Related]
5. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
Lee HJ; Kim JI; Lee JS; Jun EJ; Oh JH; Cheung DY; Chung WC; Kim BW; Kim SS
World J Gastroenterol; 2015 Jan; 21(1):351-9. PubMed ID: 25574111
[TBL] [Abstract][Full Text] [Related]
6. High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.
Sun Q; Liang X; Zheng Q; Liu W; Xiao S; Gu W; Lu H
Helicobacter; 2010 Jun; 15(3):233-8. PubMed ID: 20557366
[TBL] [Abstract][Full Text] [Related]
7. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.
Molina-Infante J; Pazos-Pacheco C; Vinagre-Rodriguez G; Perez-Gallardo B; Dueñas-Sadornil C; Hernandez-Alonso M; Gonzalez-Garcia G; Mateos-Rodriguez JM; Fernandez-Bermejo M; Gisbert JP
Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326
[TBL] [Abstract][Full Text] [Related]
8. Sequential Therapy versus Triple Therapy for the First Line Treatment of Helicobacter pylori in Korea: A Nationwide Randomized Trial.
Kim JS; Kim BW; Hong SJ; Kim JI; Shim KN; Kim JH; Baik GH; Kim SW; Song HJ; Kim JH
Gut Liver; 2016 Jul; 10(4):556-61. PubMed ID: 27114421
[TBL] [Abstract][Full Text] [Related]
9. Ten-day sequential versus triple therapy for Helicobacter pylori eradication: a prospective, open-label, randomized trial.
Chung JW; Jung YK; Kim YJ; Kwon KA; Kim JH; Lee JJ; Lee SM; Hahm KB; Lee SM; Jeong JY; Yun SC
J Gastroenterol Hepatol; 2012 Nov; 27(11):1675-80. PubMed ID: 22849546
[TBL] [Abstract][Full Text] [Related]
10. Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area.
Georgopoulos SD; Xirouchakis E; Martinez-Gonzales B; Zampeli E; Grivas E; Spiliadi C; Sotiropoulou M; Petraki K; Zografos K; Laoudi F; Sgouras D; Mentis A; Kasapidis P; Michopoulos S
Eur J Intern Med; 2016 Jul; 32():84-90. PubMed ID: 27134145
[TBL] [Abstract][Full Text] [Related]
11. Ten-day sequential therapy as first-line treatment for Helicobacter pylori infection in Korea: a retrospective study.
Kwon JH; Lee DH; Song BJ; Lee JW; Kim JJ; Park YS; Kim N; Jeong SH; Kim JW; Lee SH; Hwang JH; Jung HC; Song IS
Helicobacter; 2010 Apr; 15(2):148-53. PubMed ID: 20402817
[TBL] [Abstract][Full Text] [Related]
12. Concomitant and hybrid therapy for Helicobacter pylori infection: A randomized clinical trial.
Heo J; Jeon SW; Jung JT; Kwon JG; Lee DW; Kim HS; Yang CH; Park JB; Park KS; Cho KB; Lee SH; Jang BI;
J Gastroenterol Hepatol; 2015 Sep; 30(9):1361-6. PubMed ID: 25867608
[TBL] [Abstract][Full Text] [Related]
13. Sequential or concomitant therapy for eradication of Helicobacter pylori infection: A systematic review and meta-analysis.
Kim JS; Park SM; Kim BW
J Gastroenterol Hepatol; 2015 Sep; 30(9):1338-45. PubMed ID: 25867718
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of moxifloxacin-based sequential and hybrid therapy for first-line Helicobacter pylori eradication.
Hwang JJ; Lee DH; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 Sep; 21(35):10234-41. PubMed ID: 26401089
[TBL] [Abstract][Full Text] [Related]
15. Neither 10- nor 14-Day Sequential Treatment is better than Standard Triple Therapy for Helicobacter Pylori Eradication.
Warrington E; López-Román O; Tirado Montijo R; Urbina R; Cruz-Correa M; Toro DH
P R Health Sci J; 2016 Dec; 35(4):203-208. PubMed ID: 27898166
[TBL] [Abstract][Full Text] [Related]
16. Hybrid vs sequential therapy for eradication of Helicobacter pylori in Taiwan: A prospective randomized trial.
Chen KY; Lin TJ; Lin CL; Lee HC; Wang CK; Wu DC
World J Gastroenterol; 2015 Sep; 21(36):10435-42. PubMed ID: 26420970
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease.
Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 Apr; 21(16):5032-8. PubMed ID: 25945019
[TBL] [Abstract][Full Text] [Related]
18. Ten-day empirical sequential or concomitant therapy is more effective than triple therapy for Helicobacter pylori eradication: A multicenter, prospective study.
Chung JW; Han JP; Kim KO; Kim SY; Hong SJ; Kim TH; Kim CW; Kim JS; Kim BW; Bang BW; Kim HG; Yun SC;
Dig Liver Dis; 2016 Aug; 48(8):888-92. PubMed ID: 27257049
[TBL] [Abstract][Full Text] [Related]
19. Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea.
Kim YS; Kim SJ; Yoon JH; Suk KT; Kim JB; Kim DJ; Kim DY; Min HJ; Park SH; Shin WG; Kim KH; Kim HY; Baik GH
Aliment Pharmacol Ther; 2011 Nov; 34(9):1098-105. PubMed ID: 21923713
[TBL] [Abstract][Full Text] [Related]
20. Randomized clinical trial comparing 10- or 14-day sequential therapy and 10- or 14-day concomitant therapy for the first line empirical treatment of Helicobacter pylori infection.
Park SM; Kim JS; Kim BW; Ji JS; Choi H
J Gastroenterol Hepatol; 2017 Mar; 32(3):589-594. PubMed ID: 27505301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
